Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FFAR1 | O14842 | 3/20 | 0.52 |
| ▸ | FFAR4 | Q5NUL3 | 2/20 | 0.52 |
| ▸ | GPR84 | Q9NQS5 | 8/20 | 0.48 |
| ▸ | TSHR | P16473 | 1/20 | 0.44 |
| ▸ | FAAH | O00519 | 3/20 | 0.44 |
| ▸ | SPHK1 | Q9NYA1 | 1/20 | 0.42 |
| ▸ | PSMD14 | O00487 | 2/20 | 0.42 |
| ▸ | PLA2G1B | P04054 | 2/20 | 0.42 |
| ▸ | MMP2 | P08253 | 2/20 | 0.42 |
| ▸ | ATG4B | Q9Y4P1 | 2/20 | 0.42 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.42 |
| ▸ | RAD52 | P43351 | 1/20 | 0.42 |
| ▸ | LMNA | P02545 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9334962 | 1.00 | FFAR1 (0.52) | FFAR1FFAR4GPR84TSHRFAAH | |
| SCHEMBL11748318 | 1.00 | FFAR1 (0.52) | FFAR1FFAR4GPR84TSHRFAAH | |
| SCHEMBL9200158 | 1.00 | FFAR1 (0.52) | FFAR1FFAR4GPR84TSHRFAAH | |
| SCHEMBL1712736 | 1.00 | FFAR1 (0.52) | FFAR1FFAR4GPR84TSHRFAAH | |
| SCHEMBL1712990 | 1.00 | FFAR1 (0.52) | FFAR1FFAR4GPR84TSHRFAAH | |
| SCHEMBL910534 | 1.00 | FFAR1 (0.52) | FFAR1FFAR4GPR84TSHRFAAH | |
| SCHEMBL9685588 | 1.00 | FFAR1 (0.52) | FFAR1FFAR4GPR84TSHRFAAH | |
| SCHEMBL9685329 | 1.00 | FFAR1 (0.52) | FFAR1FFAR4GPR84TSHRFAAH | |
| SCHEMBL7065643 | 1.00 | FFAR1 (0.52) | FFAR1FFAR4GPR84TSHRFAAH | |
| SCHEMBL9200169 | 1.00 | FFAR1 (0.52) | FFAR1FFAR4GPR84TSHRFAAH |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8816095-B2 | Na channels, disease, and related assays and compositions | GEORGETOWN UNIVERSITY (US) | 2014-08-26 | — | — | US | disclosed |
| US-20110230442-A1 | NA CHANNELS, DISEASE, AND RELATED ASSAYS AND COMPOSITIONS | GEORGETOWN UNIVERSITY (US) | 2011-09-22 | — | — | US | disclosed |
| US-4983766-A | Chemical intermediates for optically active secondary alcohols | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1991-01-08 | — | — | US | disclosed |
| US-4812476-A | SECONDARY ALCOHOLS FROM ALDEHYDE AND 3-HYDROXYBUTYRIC ACID | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1989-03-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110230442-A1 | NA CHANNELS, DISEASE, AND RELATED ASSAYS AND COMPOSITIONS | CACNA1C, CACNA1B, CACNA1A | FFAR1 2112/4885FFAR4 2718/4885GPR84 495/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.